BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  FY 2022 Financial Results Announced

  Indivior PLC announced 2022 Full Year Results.

  February 16, 2023

   · 

  1 min read
• Business

  Lytix Biopharma presents fourth quarter and second half 2022 results

  Lytix Biopharma, a Norwegian immuno-oncology company, releases its fourth quarter and second half 2022 results - Steady progress towards improving cancer treatment outcomes.

  February 16, 2023

   · 

  3 min read
• Biotech Bay

  IDEAYA Biosciences to Participate in Citi’s 2023 Virtual Oncology Leadership Summit

  IDEAYA Biosciences, Inc., a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in Citi’s 2023 Virtual Oncology Leadership Summit.

  February 16, 2023

   · 

  2 min read
• BioMidwest

  Modular Devices Invests In Interim Diagnostic Imaging

  Modular Devices, a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners, announced that it has partnered with Interim Diagnostic Imaging.

  February 16, 2023

   · 

  3 min read
• Pharm Country

  Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update

  Immunic, Inc. announced that the company will release its financial results for the fourth quarter and year ended December 31, 2022, including a corporate update, on Thursday, February 23, 2023, before the opening of the U.S. financial markets.

  February 16, 2023

   · 

  4 min read
• Genetown

  Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines

  Aera Therapeutics announced its launch with a vision to harness its proprietary delivery platform to unlock the potential of genetic medicines across a wide range of modalities and therapeutic areas.

  February 16, 2023

   · 

  4 min read
• Drug Development

  Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency

  Applied Therapeutics, Inc. announced positive sorbitol reduction data from the ongoing global Phase 3 INSPIRE trial.

  February 16, 2023

   · 

  9 min read
• Business

  Blueprint Medicines Reports Fourth Quarter and Full Year 2022 Results

  Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2022.

  February 16, 2023

   · 

  15 min read